The microbiome in allergic disease: Current understanding and future opportunities—2017 PRACTALL document of the American Academy of Allergy, Asthma & Immunology and the European Academy of Allergy and Clinical Immunology

Journal of Allergy and Clinical Immunology

Volumn 139, Issue 4, 2017, Pages 1099-1110

  Huang, Yvonne J ^a   Marsland, Benjamin J ^b   Bunyavanich, Supinda ^c   O'Mahony, Liam ^d   Leung, Donald Y M ^e   Muraro, Antonella ^f   Fleisher, Thomas A ^g  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF LAUSANNE   (Switzerland)

^c MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF ZURICH   (Switzerland)

^e DEPARTMENT OF MEDICINE   (United States)

^f UNIVERSITY HOSPITAL OF PADOVA   (Italy)

^g NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

asthma; atopic dermatitis; dysbiosis; food allergy; Microbiome; microbiota; prebiotic; probiotic; systems biology

Indexed keywords

PREBIOTIC AGENT; PROBIOTIC AGENT;

ALLERGIC ASTHMA; ARTICLE; ATOPIC DERMATITIS; BACTERIAL FLORA; CLINICAL IMMUNOLOGY; DYSBIOSIS; FOOD ALLERGY; HUMAN; INTESTINE FLORA; MEDICAL SOCIETY; MICROBIAL COMMUNITY; MICROBIOME; MOLECULAR ECOLOGY; NONHUMAN; PRIORITY JOURNAL; SYSTEMS BIOLOGY; ANIMAL; HYPERSENSITIVITY; IMMUNOLOGY; MICROBIOLOGY; MICROFLORA;

ALLERGY AND IMMUNOLOGY; ANIMALS; HUMANS; HYPERSENSITIVITY; MICROBIOTA;

EID: 85017298186     PISSN: 00916749     EISSN: 10976825     Source Type: Journal    
DOI: 10.1016/j.jaci.2017.02.007     Document Type: Article

References (117)

1. 1 Rooks, M.G., Garrett, W.S., Gut microbiota: metabolites and host immunity. Nat Rev Immunol 16 (2016), 341–352.
2. 2 Carpenter, L., Beral, V., Stachan, D., Ebi-Kryston, K.L., Inskip, H., Respiratory symptoms as predictors of 27 year mortality in a representative sample of British adults. BMJ 299 (1989), 357–361.
3. 3 van Neerven, R.J., Knol, E.F., Heck, J.M., Savelkoul, H.F., Which factors in raw cow's milk contribute to protection against allergies?. J Allergy Clin Immunol 130 (2012), 853–858.
4. 4 Von Mutius, E., Radon, K., Living on a farm: impact on asthma induction and clinical course. Immunol Allergy Clin North Am 28 (2008), 631–647.
5. 5 Raciborski, F., Tomaszewska, A., Komorowski, J., Samel-Kowalik, P., Bialoszewski, A.Z., Walkiewicz, A., et al. The relationship between antibiotic therapy in early childhood and the symptoms of allergy in children aged 6-8 years—the questionnaire study results. Int J Occup Med Environ Health 25 (2012), 470–480.
6. 6 Silvers, K.M., Frampton, C.M., Wickens, K., Pattemore, P.K., Ingham, T., Fishwick, D., et al. Breastfeeding protects against current asthma up to 6 years of age. J Pediatr 160 (2012), 991–996.
7. 7 Roduit, C., Scholtens, S., de Jongste, J.C., Wijga, A.H., Gerritsen, J., Postma, D.S., et al. Asthma and 8 years of age in children born by ceasarian section. Thorax 64 (2009), 107–113.
8. 8 Fujimura, K.E., Johnson, C.C., Ownby, D.R., Cox, M.J., Brodie, E.L., Havastad, S.L., et al. Man's best friend? The effect of pet ownership on house dust microbial communities. J Allergy Clin Immunol 126 (2010), 410–412.
9. 9 Lynch, S.V., Wood, R.A., Boushey, H., Bacharier, L.B., Bloomberg, G.R., Kattan, M., et al. Effects of early-life exposure to allergens and bacteria on recurrent wheeze and atopy in urban children. J Allergy Clin Immunol 134 (2014), 593–601.e12.
10. 10 Arrieta, M.C., Stiemsma, L.T., Dimitriu, P.A., Thorson, L., Russell, S., Yurist-Doutsch, S., et al. Early infancy microbial and metabolic alterations affect risk of childhood asthma. Sci Transl Med 7 (2015), 1–14.
11. 11 Stein, M.M., Hrusch, C.L., Gozdz, J., Igartua, C., Pivniouk, V., Murray, S.E., et al. Innate immunity and asthma risk in Amish and Hutterite farm children. N Engl J Med 375 (2016), 411–421.
12. 12 McCutcheon, J.P., Moran, N.A., Extreme genome reduction in symbiotic bacteria. Nat Rev Microbiol 10 (2011), 13–26.
13. 13 Goodrich, G.K., Davenport, E.R., Beaumont, M., Jackson, M.A., Knight, R., Ober, C., et al. Genetic determinants of the gut microbiome in UK twins. Cell Host Microbe 11 (2016), 731–743.
14. 14 Clavel, T., Desmarchelier, C., Haller, D., Gérard, P., Rohn, S., Lepage, P., et al. Intestinal microbiota in metabolic diseases: from bacterial community structure and functions to species of pathophysiological relevance. Gut Microbes 5 (2014), 544–551.
15. 15 Noval Rivas, M., Crother, T.R., Arditi, M., The microbiome in asthma. Curr Opin Pediatr 6 (2016), 764–771.
16. 16 Oh, J., Byrd, A.L., Deming, C., Conlan, S. NISC Comparative Sequencing Program, Kong, H.H., Segre, J.A., Biogeography and individuality shape function in the human skin metagenome. Nature 514 (2014), 59–64.
17. 17 Weinstock, G.M., Genomic approaches to studying the human microbiota. Nature 489 (2012), 250–256.
18. 18 Cui, L., Morris, A., Ghedin, E., The human mycobiome in health and disease. Genome Med, 5, 2013, 63.
19. 19 Lim, E.S., Zhou, Y., Zhao, G., Bauer, I.K., Droit, L., Ndao, I.M., et al. Early life dynamics of the human gut virome and bacterial microbiome in infants. Nat Med 21 (2015), 1228–1234.
20. 20 Hannigan, G.D., Meisel, J.S., Tyldsley, A.S., Zheng, Q., Hodkinson, B.P., SanMiguel, A.J., et al. The human skin double-stranded DNA virome: topographical and temporal diversity, genetic enrichment, and dynamic associations with the host microbiome. MBio 6 (2015), e01578–e01615.
21. 21 Jung, W.H., Croll, D., Cho, J.H., Kim, Y.R., Lee, Y.W., Analysis of the nasal vestibule mycobiome in patients with allergic rhinitis. Mycoses 58 (2015), 167–172.
22. 22 van Woerden, H.C., Gregory, C., Brown, R., Marchesi, J.R., Hoogendoorn, B., Matthews, I.P., Differences in fungi present in induced sputum samples from asthma patients and non-atopic controls: a community based case control study. BMC Infect Dis, 13, 2013, 69.
23. 23 Kramer, R., Sauer-Heilborn, A., Welte, T., Guzman, C.A., Abraham, W.R., Höfle, M.G., Cohort study of airway mycobiome in adult cystic fibrosis patients: differences in community structure between fungi and bacteria reveal predominance of transient fungal elements. J Clin Microbiol 53 (2015), 2900–2907.
24. 24 Haldar, P., Pavord, I.D., Shaw, D.E., Berry, M.A., Thomas, M., Brightling, C.E., et al. Cluster analysis and clinical asthma phenotypes. Am J Respir Crit Care Med 178 (2008), 218–224.
25. 25 Loza, M.J., Adcock, I., Auffray, C., Chung, K.F., Djukanovic, R., Sterk, P.J., et al. Longitudinally stable, clinically defined clusters of patients with asthma independently identified in the ADEPT and U-BIOPRED asthma studies. Ann Am Thorac Soc 13:suppl 1 (2016), S102–S103.
26. 26 Modena, B.D., Tedrow, J.R., Milosevic, J., Bleecker, E.R., Meyers, D.A., Wu, W., et al. Gene expression in relation to exhaled nitric oxide identifies novel asthma phenotypes with unique biomolecular pathways. Am J Respir Crit Care Med 190 (2014), 1363–1372.
27. 27 Moore, W.C., Fitzpatrick, A.M., Li, X., Hastie, A.T., Li, H., Meyers, D.A., et al. Clinical heterogeneity in the severe asthma research program. Ann Am Thorac Soc 10:suppl (2013), S118–S124.
28. 28 Fahy, J.V., Type 2 inflammation in asthma—present in most, absent in many. Nat Rev Immunol 15 (2015), 57–65.
29. 29 Smits, H.H., Hiemstra, P.S., Prazeres da Costa, C., Ege, M., Edwards, M., Garn, H., et al. Microbes and asthma: opportunities for intervention. J Allergy Clin Immunol 137 (2016), 690–697.
30. 30 Sutherland, E.R., Martin, R.J., Asthma and atypical bacterial infection. Chest 132 (2007), 1962–1966.
31. 31 Casadevall, A., Pirofski, L.A., Microbiology: ditch the term pathogen. Nature 516 (2014), 165–166.
32. 32 Byrd, A.L., Segre, J.A., Infectious disease. Adapting Koch's postulates. Science 351 (2016), 224–226.
33. 33 Denner, D.R., Sangwan, N., Becker, J.B., Hogarth, D.K., Oldham, J., Castillo, J., et al. Corticosteroid therapy and airflow obstruction influence the bronchial microbiome, which is distinct from that of bronchoalveolar lavage in asthmatic airways. J Allergy Clin Immunol 137 (2016), 1398–1405.e3.
34. 34 Huang, Y.J., Nariya, S., Harris, J.M., Lynch, S.V., Choy, D.F., Arron, J.R., et al. The airway microbiome in patients with severe asthma: Associations with disease features and severity. J Allergy Clin Immunol 136 (2015), 874–884.
35. 35 Huang, Y.J., Nelson, C.E., Brodie, E.L., Desantis, T.Z., Baek, M.S., Liu, J., et al. Airway microbiota and bronchial hyperresponsiveness in patients with suboptimally controlled asthma. J Allergy Clin Immunol 127 (2011), 372–381 e1-3.
36. 36 Marri, P.R., Stern, D.A., Wright, A.L., Billheimer, D., Martinez, F.D., Asthma-associated differences in microbial composition of induced sputum. J Allergy Clin Immunol 131 (2013), 346–352 e1-3.
37. 37 Simpson, J.L., Daly, J., Baines, K.J., Yang, I.A., Upham, J.W., Reynolds, P.N., et al. Airway dysbiosis: Haemophilus influenzae and Tropheryma in poorly controlled asthma. Eur Respir J 47 (2016), 792–800.
38. 38 Teo, S.M., Mok, D., Pham, K., Kusel, M., Serralha, M., Troy, N., et al. The infant nasopharyngeal microbiome impacts severity of lower respiratory infection and risk of asthma development. Cell Host Microbe 17 (2015), 704–715.
39. 39 Goleva, E., Jackson, L.P., Harris, J.K., Robertson, C.E., Sutherland, E.R., Hall, C.F., et al. The effects of airway microbiome on corticosteroid responsiveness in asthma. Am J Respir Crit Care Med 188 (2013), 1193–1201.
40. 40 Durack, J., Lynch, S.V., Nariya, S., Bhakta, N.R., Beigelman, A., Castro, M., et al. Features of the bronchial bacterial microbiome associated with atopy, asthma and responsiveness to inhaled corticosteroid treatment. J Allergy Clin Immunol, 2016 [Epub ahead of print].
41. 41 Barcik, W., Pugin, B., Westernann, P., Perez, N.R., Ferst, R., Wawrzyniak, M., et al. Histamine-secreting microbes are increased in the gut of adult asthma patients. J Allergy Clin Immunol 138 (2016), 1491–1494.
42. 42 Hilty, M., Burke, C., Pedro, H., Cardenas, P., Bush, A., Bossley, C., et al. Disordered microbial communities in asthmatic airways. PLoS One, 5, 2010 e8578.
43. 43 Green, B.J., Wiriyachaiporn, S., Grainge, C., Rogers, G.B., Kehagia, V., Lau, L., et al. Potentially pathogenic airway bacteria and neutrophilic inflammation in treatment resistant severe asthma. PLoS One, 9, 2014 e100645.
44. 44 Fujimura, K.E., Sitarik, A.R., Havstad, S., Lin, D.L., Levan, S., Fadrosh, D., et al. Neonatal gut microbiota associates with childhood multisensitized atopy and T cell differentiation. Nat Med 22 (2016), 1187–1191.
45. 45 Herbst, T., Sichelstiel, A., Schar, C., Yadava, K., Burki, K., Cahenzli, J., et al. Dysregulation of allergic airway inflammation in the absence of microbial colonization. Am J Respir Crit Care Med 184 (2011), 198–205.
46. 46 Gollwitzer, E.S., Saglani, S., Trompette, A., Yadava, K., Sherburn, R., McCoy, K.D., et al. Lung microbiota promotes tolerance to allergens in neonates via PD-L1. Nat Med 20 (2014), 642–647.
47. 47 Olszak, T., An, D., Zeissig, S., Vera, M.P., Richter, J., Franke, A., et al. Microbial exposure during early life has persistent effects on natural killer T cell function. Science 336 (2012), 489–493.
48. 48 Ege, M.J., Mayer, M., Normand, A.C., Genuneit, J., Cookson, W.O., Braun-Fahrlander, C., et al. Exposure to environmental microorganisms and childhood asthma. N Engl J Med 364 (2011), 701–709.
49. 49 Schuijs, M.J., Willart, M.A., Vergote, K., Gras, D., Deswarte, K., Ege, M.J., et al. Farm dust and endotoxin protect against allergy through A20 induction in lung epithelial cells. Science 349 (2015), 1106–1110.
50. 50 Hammad, H., Chieppa, M., Perros, F., Willart, M.A., Germain, R.N., Lambrecht, B.N., House dust mite allergen induces asthma via Toll-like receptor 4 triggering of airway structural cells. Nat Med 15 (2009), 410–416.
51. 51 Debarry, J., Garn, H., Hanuszkiewicz, A., Dickgreber, N., Blumer, N., von Mutius, E., et al. Acinetobacter lwoffii and Lactococcus lactis strains isolated from farm cowsheds possess strong allergy-protective properties. J Allergy Clin Immunol 119 (2007), 1514–1521.
52. 52 Nembrini, C., Sichelstiel, A., Kisielow, J., Kurrer, M., Kopf, M., Marsland, B.J., Bacterial-induced protection against allergic inflammation through a multicomponent immunoregulatory mechanism. Thorax 66 (2011), 755–763.
53. 53 Hollingsworth, J.W., Whitehead, G.S., Lin, K.L., Nakano, H., Gunn, M.D., Schwartz, D.A., et al. TLR4 signaling attenuates ongoing allergic inflammation. J Immunol 176 (2006), 5856–5862.
54. 54 Yadava, K., Pattaroni, C., Sichelstiel, A.K., Trompette, A., Gollwitzer, E.S., Salami, O., et al. Microbiota promotes chronic pulmonary inflammation by enhancing IL-17A and autoantibodies. Am J Respir Crit Care Med 193 (2016), 975–987.
55. 55 Bernasconi, E., Pattaroni, C., Koutsokera, A., Pison, C., Kessler, R., Benden, C., et al. Airway microbiota determines innate cell inflammatory or tissue remodeling profiles in lung transplantation. Am J Respir Crit Care Med 194 (2016), 1252–1263.
56. 56 Marsland, B.J., Gollwitzer, E.S., Host-microorganism interactions in lung diseases. Nat Rev Immunol 14 (2014), 827–835.
57. 57 Trompette, A., Gollwitzer, E.S., Yadava, K., Sichelstiel, A.K., Sprenger, N., Ngom-Bru, C., et al. Gut microbiota metabolism of dietary fiber influences allergic airway disease and hematopoiesis. Nat Med 20 (2014), 159–166.
58. 58 Vos, A.P., M'Rabet, L., Stahl, B., Boehm, G., Garssen, J., Immune-modulatory effects and potential working mechanisms of orally applied nondigestible carbohydrates. Crit Rev Immunol 27 (2007), 97–140.
59. 59 Verheijden, K.A., Willemsen, L.E., Braber, S., Leusink-Muis, T., Delsing, D.J., Garssen, J., et al. Dietary galacto-oligosaccharides prevent airway eosinophilia and hyperresponsiveness in a murine house dust mite-induced asthma model. Respir Res, 16, 2015, 17.
60. 60 Choi, J.H., Oh, S.W., Kang, M.S., Kwon, H.J., Oh, G.T., Kim, D.Y., Trichostatin A attenuates airway inflammation in mouse asthma model. Clin Exp Allergy 35 (2005), 89–96.
61. 61 Thorburn, A.N., McKenzie, C.I., Shen, S., Stanley, D., Macia, L., Mason, L.J., et al. Evidence that asthma is a developmental origin disease influenced by maternal diet and bacterial metabolites. Nat Commun, 6, 2015, 7320.
62. 62 Denning, D.W., O'Driscoll, B.R., Hogaboam, C.M., Bowyer, P., Niven, R.M., The link between fungi and severe asthma: a summary of the evidence. Eur Respir J 27 (2006), 615–626.
63. 63 Zelante, T., Pieraccini, G., Scaringi, L., Aversa, F., Romani, L., Learning from other diseases: protection and pathology in chronic fungal infections. Semin Immunopathol 38 (2016), 239–248.
64. 64 Wheeler, M.L., Limon, J.J., Bar, A.S., Leal, C.A., Gargus, M., Tang, J., et al. Immunological consequences of intestinal fungal dysbiosis. Cell Host Microbe 19 (2016), 865–873.
65. 65 Muraro, A., Lemanske, R.F. Jr., Hellings, P.W., Torres, M.J., Khan, D., Simon, H.U., et al. Precision medicine in patients with allergic diseases: airway disease and atopic dermatitis— PRACTALL document of the European Academy of Allergy and Clinical Immunology and the American Academy of Allergy, Asthma & Immunology. J Allergy Clin Immunol 137 (2016), 1347–1358.
66. 66 Werfel, T., Allam, J.P., Biedermann, T., Eyerich, K., Gilles, S., Guttman-Yassky, E., et al. Cellular and molecular immunologic mechanisms in patients with atopic dermatitis. J Allergy Clin Immunol 138 (2016), 336–349.
67. 67 Egawa, G., Kabashima, K., Multifactorial skin barrier deficiency and atopic dermatitis: Essential topics to prevent the atopic march. J Allergy Clin Immunol 138 (2016), 350–385.e1.
68. 68 Williams, M.R., Gallo, R.L., The role of the skin microbiome in atopic dermatitis. Curr Allergy Asthma Rep, 15, 2015, 65.
69. 69 Jones, A.L., Curran-Everett, D., Leung, D.Y.M., Food allergy is associated with Staphylococcus aureus colonization in children with atopic dermatitis. J Allergy Clin Immunol 137 (2016), 1247–1248.
70. 70 Tauber, M., Balica, S., Hsu, C.Y., Jean-Decoster, C., Lauze, C., Redoules, D., et al. Staphylococcus aureus density on lesional and nonlesional skin is strongly associated with disease severity in atopic dermatitis. J Allergy Clin Immunol 137 (2016), 1272–1274.
71. 71 Beck, L.A., Thaçi, D., Hamilton, J.D., Graham, N.M., Bieber, T., Rocklin, R., et al. Dupilumab treatment in adults with moderate-to-severe atopic dermatitis. N Engl J Med 371 (2014), 130–139.
72. 72 Kong, H.H., Oh, J., Deming, C., Conlan, S., Grice, E.A., Beatson, M.A., et al. Temporal shifts in the skin microbiome associated with disease flares and treatment in children with atopic dermatitis. Genome Res 22 (2012), 850–859.
73. 73 Lynde, C.W., Andriessen, A., Bertucci, V., McCuaig, C., Skotnicki, S., Weinstein, M., et al. The skin microbiome in atopic dermatitis and its relationship to emollients. J Cutan Med Surg 20 (2016), 21–28.
74. 74 Grice, E.A., The intersection of microbiome and host at the skin interface: genomic- and metagenomic-based insights. Genome Res 25 (2015), 1514–1520.
75. 75 Perez, G.I., Gao, Z., Jourdain, R., Ramirez, J., Gany, F., Clavaud, C., et al. Body site is a more determinant factor than human population diversity in the healthy skin microbiome. PLoS One, 11, 2016, e0151990.
76. 76 Shi, B., Bangayan, N.J., Curd, E., Taylor, P.A., Gallo, R.L., Leung, D.Y., et al. The skin microbiome is different in pediatric versus adult atopic dermatitis. J Allergy Clin Immunol 138 (2016), 1233–1236.
77. 77 Sugimoto, S., Iwamoto, T., Takada, K., Okuda, K., Taijma, A., Iwase, T., et al. Staphylococcus epidermidis especially degrades specific proteins associated with Staphylococcus aureus biofilm formation and host-pathogen interaction. J Bacteriol 195 (2013), 1645–1655.
78. 78 Nakatsuji, T., Chen, T.H., Narala, S., Chun, K.A., Two, A.M., Yun, T., et al. Antimicrobials from human skin commensal bacteria protect against Staphylococcus aureus and are deficient in atopic dermatitis. Sci Transl Med, 9(378), 2017, 10.1126/scitranslmed.aah4680.
79. 79 Otto, M., Staphylococcus colonization of the skin and antimicrobial peptides. Expert Rev Dermatol 5 (2010), 183–195.
80. 80 Yuki, T., Yoshida, H., Akazawa, Y., Komiya, A., Sugiyama, Y., Inoue, S., Activation of TLR2 enhances tight junction barrier in epidermal keratinocytes. J Immunol 187 (2011), 3230–3237.
81. 81 Beck, L.A., Boguniewicz, M., Hata, T.R., Schneider, L.C., Hanifin, J.M., Gallo, R.L., et al. Phenotype of atopic dermatitis: subjects with a history of eczema herpeticum. J Allergy Clin Immunol 124 (2009), 260–269.
82. 82 Leung, D.Y.M., Why is eczema herpeticum unexpectedly rare?. Antiviral Res 98 (2013), 153–157.
83. 83 Bin, L., Edwards, M.G., Heiser, R., Streib, J.E., Richers, B., Hall, C.F., et al. Identification of novel gene signatures in patients with atopic dermatitis complicated by eczema herpeticum. J Allergy Clin Immunol 134 (2014), 848–855.
84. 84 Gao, L., Bin, L., Rafaels, N.M., Huang, L., Potee, J., Ruczinski, I., et al. Targeted deep sequencing identifies rare loss of-function variants in IFNGR1 for risk of atopic dermatitis complicated by eczema herpeticum. J Allergy Clin Immunol 136 (2015), 1591–1600.
85. 85 Oyoshi, M.K., Venturelli, N., Geha, R.S., Thymic stromal lymphopoietin and IL-33 promote skin inflammation and vaccinia virus replication in a mouse model of atopic dermatitis. J Allergy Clin Immunol 138 (2016), 283–286.
86. 86 Berin, M.C., Sampson, H.A., Mucosal immunology of food allergy. Curr Biol 23 (2013), R389–R400.
87. 87 Thompson-Chagoyan, O.C., Vieites, J.M., Maldonado, J., Edwards, C., Gil, A., Changes in faecal microbiota of infants with cow's milk protein allergy—a Spanish prospective case-control 6-month follow-up study. Pediatr Allergy Immunol 21 (2010), e394–e400.
88. 88 Berni Canani, R., Sangwan, N., Stefka, A.T., Nocerino, R., Paparo, L., Aitoro, R., et al. Lactobacillus rhamnosus GG-supplemented formula expands butyrate-producing bacterial strains in food allergic infants. ISME J 10 (2016), 742–750.
89. 89 Bunyavanich, S., Shen, N., Grishin, A., Wood, R., Burks, W., Dawson, P., et al. Early-life gut microbiome composition and milk allergy resolution. J Allergy Clin Immunol 138 (2016), 1122–1130.
90. 90 Hua, X., Goedert, J.J., Pu, A., Yu, G., Shi, J., Allergy associations with the adult fecal microbiota: analysis of the American Gut Project. EBioMedicine 3 (2016), 172–179.
91. 91 Noval Rivas, M., Burton, O.T., Wise, P., Zhang, Y.-q., Hobson, S.A., Garcia Lloret, M., et al. A microbiota signature associated with experimental food allergy promotes allergic sensitization and anaphylaxis. J Allergy Clin Immunol 131 (2013), 201–212.
92. 92 Atarashi, K., Tanoue, T., Oshima, K., Suda, W., Nagano, Y., Nishikawa, H., et al. Treg induction by a rationally selected mixture of Clostridia strains from the human microbiota. Nature 500 (2013), 232–236.
93. 93 Stefka, A.T., Feehley, T., Tripathi, P., Qiu, J., McCoy, K., Mazmanian, S.K., et al. Commensal bacteria protect against food allergen sensitization. Proc Natl Acad Sci U S A 111 (2014), 13145–13150.
94. 94 Chinthrajah, R.S., Hernandez, J.D., Boyd, S.D., Galli, S.J., Nadeau, K.C., Molecular and cellular mechanisms of food allergy and food tolerance. J Allergy Clin Immunol 137 (2016), 984–997.
95. 95 Macia, L., Tan, J., Vieira, A.T., Leach, K., Stanley, D., Luong, S., et al. Metabolite-sensing receptors GPR43 and GPR109A facilitate dietary fibre-induced gut homeostasis through regulation of the inflammasome. Nat Commun, 6, 2015, 6734.
96. 96 Hol, J., van Leer, E.H., Elink Schuurman, B.E., de Ruiter, L.F., Samsom, J.N., Hop, W., et al. The acquisition of tolerance toward cow's milk through probiotic supplementation: a randomized, controlled trial. J Allergy Clin Immunol 121 (2008), 1448–1454.
97. 97 Berni Canani, R., Nocerino, R., Terrin, G., Coruzzo, A., Cosenza, L., Leone, L., et al. Effect of Lactobacillus GG on tolerance acquisition in infants with cow's milk allergy: a randomized trial. J Allergy Clin Immunol 129 (2012), 580–582 e1-5.
98. 98 Tang, M.L., Ponsonby, A.L., Orsini, F., Tey, D., Robinson, M., Su, E.L., et al. Administration of a probiotic with peanut oral immunotherapy: a randomized trial. J Allergy Clin Immunol 135 (2015), 737–744.e8.
99. 99 Azad, M.B., Konya, T., Guttman, D.S., Field, C.J., Sears, M.R., HayGlass, K.T., et al. Infant gut microbiota and food sensitization: associations in the first year of life. Clin Exp Allergy 45 (2015), 632–643.
100. 100 Cahenzli, J., Koller, Y., Wyss, M., Geuking, M.B., McCoy, K.D., Intestinal microbial diversity during early-life colonization shapes long-term IgE levels. Cell Host Microbe 14 (2013), 559–570.
101. 101 Frei, R., Akdis, M., O'Mahony, L., Prebiotics, probiotics, synbiotics, and the immune system: experimental data and clinical evidence. Curr Opin Gastroenterol 31 (2015), 153–158.
102. 102 Lyons, A., O'Mahony, D., O'Brien, F., MacSharry, J., Sheil, B., Ceddia, M., et al. Bacterial strain-specific induction of Foxp3+ T regulatory cells is protective in murine allergy models. Clin Exp Allergy 40 (2010), 811–819.
103. 103 Sonnenburg, J.L., Bäckhed, F., Diet-microbiota interactions as moderators of human metabolism. Nature 535 (2016), 56–64.
104. 104 Roduit, C., Frei, R., Depner, M., Schaub, B., Loss, G., Genuneit, J., et al. Increased food diversity in the first year of life is inversely associated with allergic diseases. J Allergy Clin Immunol 133 (2014), 1056–1064.
105. 105 van Nood, E., Dijkgraaf, M.G., Keller, J.J., Duodenal infusion of feces for recurrent Clostridium difficile. N Engl J Med, 368, 2013, 2145.
106. 106 Youngster, I., Russell, G.H., Pindar, C., Ziv-Baran, T., Sauk, J., Hohmann, E.L., Oral, capsulized frozen fecal mcrobiolota transplantation for relapsing Clostridium difficile infection. JAMA 312 (2014), 1772–1778.
107. 107 Bokulich, N.A., Chung, J., Battaglia, T., Henderson, N., Jay, M., Li, H., et al. Antibiotics, birth mode, and diet shape microbiome maturation during early life. Sci Transl Med, 8, 2016, 343ra82.
108. 108 Dominguez-Bello, M.G., De Jesus-Laboy, K.M., Shen, N., Cox, L.M., Amir, A., Gonzalez, A., et al. Partial restoration of the microbiota of cesarean-born infants via vaginal microbial transfer. Nat Med 22 (2016), 250–253.
109. 109 Waldor, M.K., Tyson, G., Borenstein, E., Ochman, H., Moeller, A., Finlay, B.B., et al. Where next for microbiome research?. PLoS Biol, 13, 2015, e1002050.
110. 110 Bunyavanich, S., Schadt, E.E., Systems biology of asthma and allergic diseases: a multiscale approach. J Allergy Clin Immunol 135 (2015), 31–42.
111. 111 Schadt, E.E., Bjorkegren, J.L., NEW: network-enabled wisdom in biology, medicine, and health care. Sci Transl Med, 4, 2012, 115rv1.
112. 112 Chen, Y., Zhu, J., Lum, P.Y., Yang, X., Pinto, S., MacNeil, D.J., et al. Variations in DNA elucidate molecular networks that cause disease. Nature 452 (2008), 429–435.
113. 113 Miller, C.L., Pjanic, M., Wang, T., Nguyen, T., Cohain, A., Lee, J.D., et al. Integrative functional genomics identifies regulatory mechanisms at coronary artery disease loci. Nat Commun, 7, 2016, 12092.
114. 114 Zhang, B., Gaiteri, C., Bodea, L.G., Wang, Z., McElwee, J., Podtelezhnikov, A.A., et al. Integrated systems approach identifies genetic nodes and network. Cell 153 (2013), 707–720.
115. 115 Jostins, L., Ripke, S., Weersma, R.K., Duerr, R.H., McGovern, D.P., Hui, K.Y., et al. Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature 491 (2012), 119–124.
116. 116 Virgin, H.W., Todd, J.A., Metagenomics and personalized medicine. Cell 147 (2011), 44–56.
117. 117 Dobrin, R., Zhu, J., Molony, C., Argman, C., Parrish, M.L., Carlson, S., et al. Multi-tissue coexpression networks reveal unexpected subnetworks associated with disease. Genome Biol, 10, 2009, R55.